Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Empower Clinics Inc EPWCF

Empower Clinics Inc. is a Canada-based integrated healthcare and medical device company with multi-disciplinary clinics. The Company provides body and mind wellness for patients through its medical clinics, digital and telemedicine care, medical diagnostics laboratories, and sale of medical devices. Its segments include Health & Wellness, comprising clinic operations, patient visits, and... see more

GREY:EPWCF - Post Discussion

Empower Clinics Inc > Great News!
View:
Post by GalAnonymous on Oct 04, 2021 8:36am

Great News!

VANCOUVER BC / ACCESSWIRE / October 4, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(OTCQB:EPWCF)(FRA:8EC) ("Empower" or the "Company") an integrated healthcare company serving patients through medical centers, telemedicine platforms, a medical device company, and a high complexity medical diagnostics laboratory processing COVID-19 specimens and developing a variety of direct to consumer testing protocols, is pleased to announce that its wholly-owned subsidiary Medi + Sure Canada Inc. ("MediSure") has entered into a Pilot Agreement ("Pilot") with Care Group of Pharmacies ("Care Group") to carry MediSure diabetes management medical devices in their pharmacies.

NEWLY ACQUIRED MEDISURE PLACES DIABETES MEDICAL DEVICES ON SHELVES OF ONE OF CANADA'S FASTEST GROWING PHARMACY GROUPS

Care Group is one of Canada's fastest growing pharmacy groups with numerous locations across six provinces. Its independent pharmacy model blends local healthcare operations with industry-leading resources that ensure best in quality patient services. MediSure is a leading Canadian provider of medical devices that manages diabetes. A trusted national brand focused on diabetes solutions, diabetes education and solutions that create positive outcomes for patients.

With the support of Empower, MediSure has entered into a pilot agreement with Care Group to add its diabetes products to their shelves, including best-in-class Blood Glucose Monitoring (BGM) products, test strips and other products that positively impact the daily lives of many Canadians.

"We only recently completed the acquisition of Medisure, and with additional resources and access to our pharmacy network, the MediSure team are securing new opportunities that provide immediate increased shelf-space, new orders and increased revenue." said Steven McAuley, Chairman and CEO of Empower Clinics. "This is just the beginning of how the MediSure brand will grow, how it will bring additional medical devices to market, utilizing more than a decade of regulatory experience to gain access to the U.S and other global markets going forward."

"I'm honoured to begin working with another proud Canadian company on one of the leading healthcare issues facing our country." states Mr. McAuley, "No Canadian should be without affordable, best-in-class products when it comes to managing diabetes. By working with Care Group, we are connecting sought-after diabetic management products with a robust network of independent pharmacists from coast to coast. This is only the beginning of what I expect to be a wonderful relationship focused on elevating the frontline care provided by Care Group pharmacists."

DETAILS OF 6-MONTH PILOT PROGRAM

The objective of this program is to provide diabetes management solutions to Care Group through their independent pharmacy platform for resale and distribution to their Independent Pharmacy Partners. To this end, the Parties will commence a six-month pilot program to evaluate costs and revenue opportunities to best determine the final business model that will serve Care Group patients and their corporate accounts. The Parties will evaluate the complete program with the objective to enter into a definitive agreement for a nationwide rollout.

Empower will provide Health Canada Approved MediSure Diabetes Management Solutions, express shipping on all ordered units and technical support. The resale and distribution of MediSure products includes, but is not limited to, Blood Glucose Monitoring, Test Strips and Lancing Devices.

MEDISURE ADDRESSES MARKET THAT IS IMPACTING 1 IN 4 CANADIANS … AND GETTING WORSE

1 in 4 Canadians suffer from pre-diabetes or type I and type II diabetes, resulting in a medical crisis that is not only failing to improve - but tragically worsening.

Between 2000 and 2016, the prevalence of Canadians living with diabetes increased by an average of 3.3% each year. According to Statistics Canada, on average, 549 Canadians are diagnosed with diabetes each day, and 11% of Canadian adults aged 20+ are currently living with diabetes. The rate of those diagnosed is expected to increase in the years to come alongside patient demands on the healthcare system as Canadians are living with diabetes longer. This demand begets the need for a range of affordable, high-quality diabetic management products.

 
Comment by Illiter8 on Oct 04, 2021 9:38am
Bahahahah anyone else notice how they never full out sign an agreement? It is always a potential contract if the results are there..... you think maybe these companies dont trust a greasy car salesman as well?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities